关键词:Diphtheria toxin, DT, NAD(+)--diphthamide ADP-ribosyltransferase, Diphtheria toxin fragment A, Diphtheria toxin fragment B, CRM197, Nontoxic Diphtheria Toxin,重组CRM197蛋白,白喉毒素
一 、产品描述
CRM197是一种将52位的甘氨酸替换为谷氨酸的单一突变的无毒性的白喉毒素突变体,致使白喉毒素酶活性位点发生改变,从而不能对细胞产生毒性作用,但在抗原性和免疫原性上仍和天然白喉毒素保持一致。CRM197是一种研究明确的蛋白质,作为多糖和半抗原的载体使其具有免疫原性。它被用作一种载体蛋白,用于许多已经被批准的疫苗,比如脑膜炎球菌、乙型流感嗜血杆菌和肺炎球菌感染的结合疫苗。
二 、抗体详情
Recombinant CRM197 (Nontoxic Diphtheria Toxin) (YXX05401)
表达系统 |
E. coli |
形态 |
Lyophilized |
纯度 |
>90% as determined by SDS-PAGE. |
UniProt |
P00587 |
应用 |
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress |
注意 |
仅供科研使用 |
三、 已发表文献
Diphtheria toxin mutant CRM197 is an inhibitor of protein synthesis that induces cellular toxicity. PMID: 17988701 |
Diphtheria toxin mutant CRM197-mediated transcytosis across blood-brain barrier in vitro. PMID: 20082134 |
Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway. PMID: 30374472 |
Biochemical and biological characteristics of cross-reacting material 197 CRM197, a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications. PMID: 21715186 |
Overexpression and purification of the recombinant diphtheria toxin variant CRM197 in Escherichia coli. PMID: 21889551 |
佰乐博生物作为法国AntibodySystem在亚洲的总代理,提供近30,000种生命科学试剂,核心产品涵盖蛋白、抗体和试剂盒,旨在为科研工作者提供专业、全面、可靠的试剂支持,推动生命科学研究的深入发展。
试剂 | 耗材 | 定制 | 实验服务 | 供应链
免费热线:027-65279366 /18108604356
QQ:2663991332
咨询邮箱:info@biolabreagent.com